S Rössner

2.2k total citations
38 papers, 1.6k citations indexed

About

S Rössner is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, S Rössner has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Physiology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in S Rössner's work include Pharmacology and Obesity Treatment (7 papers), Obesity, Physical Activity, Diet (5 papers) and Adipose Tissue and Metabolism (5 papers). S Rössner is often cited by papers focused on Pharmacology and Obesity Treatment (7 papers), Obesity, Physical Activity, Diet (5 papers) and Adipose Tissue and Metabolism (5 papers). S Rössner collaborates with scholars based in Sweden, United States and United Kingdom. S Rössner's co-authors include Martin Neovius, Erik Näslund, Yvonne Linné, Per M. Hellström, Britta Barkeling, John E. Blundell, N A King, M. Gutniak, Jens J. Holst and Mikael Rydén and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

S Rössner

35 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Rössner Sweden 19 529 449 353 319 272 38 1.6k
E. Ur Canada 16 399 0.8× 403 0.9× 236 0.7× 414 1.3× 180 0.7× 29 1.6k
A Fernández‐Cruz Spain 20 579 1.1× 417 0.9× 178 0.5× 392 1.2× 161 0.6× 59 1.8k
Sylvie Pinault Canada 8 1.0k 2.0× 494 1.1× 197 0.6× 516 1.6× 250 0.9× 10 2.0k
Ramin Alemzadeh United States 28 395 0.7× 1.0k 2.2× 609 1.7× 268 0.8× 177 0.7× 80 2.3k
Z Fuchs Israel 14 603 1.1× 888 2.0× 197 0.6× 249 0.8× 119 0.4× 20 1.9k
Tania Markovic Australia 24 909 1.7× 431 1.0× 506 1.4× 628 2.0× 173 0.6× 85 2.1k
R. R. Fabsitz United States 25 477 0.9× 701 1.6× 379 1.1× 491 1.5× 108 0.4× 37 2.4k
Joseph Paul O’Hare United Kingdom 22 650 1.2× 661 1.5× 211 0.6× 156 0.5× 324 1.2× 42 2.2k
Karen R. Kelly United States 25 903 1.7× 468 1.0× 514 1.5× 185 0.6× 132 0.5× 71 2.2k
A Nadeau Canada 13 660 1.2× 537 1.2× 169 0.5× 412 1.3× 91 0.3× 20 1.5k

Countries citing papers authored by S Rössner

Since Specialization
Citations

This map shows the geographic impact of S Rössner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Rössner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Rössner more than expected).

Fields of papers citing papers by S Rössner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Rössner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Rössner. The network helps show where S Rössner may publish in the future.

Co-authorship network of co-authors of S Rössner

This figure shows the co-authorship network connecting the top 25 collaborators of S Rössner. A scholar is included among the top collaborators of S Rössner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Rössner. S Rössner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collado, Aida, Jiangning Yang, Michael Alvarsson, et al.. (2024). Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase. Clinical Science. 138(15). 975–985. 2 indexed citations
2.
Hagström, Hannes, et al.. (2024). Successful Example of Implementing Screening of Liver Fibrosis in Specialist Diabetes Care. SHILAP Revista de lepidopterología. 4(3). 100577–100577.
3.
Andersson, Daniel P., Jesper Bäckdahl, Johan Hoffstedt, et al.. (2015). Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss. International Journal of Obesity. 39(6). 893–898. 65 indexed citations
4.
Rössner, S. (2013). The obese uremic patient: a newcomer in the nephrology clinic?. Nephrology Dialysis Transplantation. 28(suppl 4). iv117–iv119. 1 indexed citations
5.
Rössner, S, et al.. (2010). Glucose metabolism and body composition in young adults treated with TBI during childhood. Bone Marrow Transplantation. 46(10). 1303–1308. 32 indexed citations
6.
Astrup, Arne, et al.. (2009). Treatment with Liraglutide, a Once-Daily Human GLP-1 Analog, for 52 Weeks Reduces Weight and Waist Circumference: A Randomized Placebo-Controlled Trial. UCL Discovery (University College London). 1 indexed citations
7.
Stenlöf, Kaj, S Rössner, Frank Vercruysse, et al.. (2006). Topiramate in the treatment of obese subjects with drug‐naive type 2 diabetes. Diabetes Obesity and Metabolism. 9(3). 360–368. 63 indexed citations
8.
Carraro, Raffaele, Nick Finer, Marie Kunešová, et al.. (2003). 2003 William J. Stickel Silver Award. Skin temperatures as a one-time screening tool do not predict future diabetic foot complications. UCL Discovery (University College London). 2 indexed citations
9.
Astrup, Arne, S Toubro, Nick Finer, et al.. (2001). Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. International Journal of Obesity. 25(4). 496–501. 85 indexed citations
10.
Eriksson, Per, et al.. (2000). Excessive fat accumulation is associated with the TNFα -308 G/A promoter polymorphism in women but not in men. Diabetologia. 43(1). 117–120. 107 indexed citations
11.
Näslund, Erik, Britta Barkeling, N A King, et al.. (1999). Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.. International Journal of Obesity. 23(3). 304–311. 366 indexed citations
12.
Waldenström, Ulla, et al.. (1997). An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer. Human Reproduction. 12(9). 2057–2060. 136 indexed citations
13.
Wolk, Alicja & S Rössner. (1996). Obesity and self-perceived health in Sweden.. PubMed. 20(4). 369–72. 27 indexed citations
14.
Kjellin, A., Stig Ramel, S Rössner, & K Thor. (1996). Gastroesophageal Reflux in Obese Patients Is Not Reduced by Weight Reduction. Scandinavian Journal of Gastroenterology. 31(11). 1047–1051. 125 indexed citations
15.
Rössner, S. (1992). Pregnancy, weight cycling and weight gain in obesity.. PubMed. 16(2). 145–7. 86 indexed citations
16.
Rössner, S. (1978). [Do blood lipids go up when blood pressure goes down?].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 75(35). 2943–4. 1 indexed citations
17.
Nikkilä, E, Anders Olsson, S Rössner, Göran Walldius, & Lars A. Carlson. (1976). Effect of Gemfibrozil on Lipoprotein Concentrations in Different Types of Hyperlipoproteinæmia. Proceedings of the Royal Society of Medicine. 69(2_suppl). 28–31. 20 indexed citations
18.
Rössner, S, B Eklund, U. Freyschuss, et al.. (1976). Elimination of parenterally administered fat. Studies on removal sites for intralipid in normo-and hyperlipidaemic subjects.. PubMed. 466. 56–7. 7 indexed citations
19.
Rössner, S. (1974). Medical education in the Nordic countries.. PubMed. 89(7). 209–12.
20.
Rössner, S. (1973). The intravenous fat tolerance test with intralipid in various types of hyperlipidaemias and comparison between metabolism of intralipid and VLDL.. PubMed. 38. 69–85. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Ur Breakdown of academic impact, for papers by A Fernández‐Cruz Breakdown of academic impact, for papers by Sylvie Pinault Breakdown of academic impact, for papers by Ramin Alemzadeh Breakdown of academic impact, for papers by Z Fuchs Breakdown of academic impact, for papers by Tania Markovic Breakdown of academic impact, for papers by R. R. Fabsitz Breakdown of academic impact, for papers by Joseph Paul O’Hare Breakdown of academic impact, for papers by Karen R. Kelly Breakdown of academic impact, for papers by A Nadeau
Rankless by CCL
2026